Vanta Holdings Inc. (VNTXF)

OTCMKTS · Delayed Price · Currency is USD
1.500
0.00 (0.00%)
At close: Feb 18, 2026
Market Cap4.08M -43.0%
Revenue (ttm)148.16K +164.9%
Net Income-6.98M
EPS-2.11
Shares Out n/a
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume193
Open1.500
Previous Close1.500
Day's Range1.500 - 1.500
52-Week Range0.019 - 3.000
Beta-0.38
Analystsn/a
Price Targetn/a
Earnings DateJun 5, 2026

About Vanta Holdings

Vanta Holdings Inc. operates as a lifestyle and wellness consumer packaged goods company in Canada and the United States. It operates through Alkaline and Mineralized Beverages; and Supplements and e-Commerce segments. The company develops, manufactures and markets Blackwater and alkaline waters, concentrates, and shots under the TRACE brand to retailers and online, as well as engages in the direct-to-consumer sale of natural health products, including nutraceutical and hemp-based CBD products through e-commence platform. It also provides CBD b... [Read more]

Founded 2017
Employees 2
Stock Exchange OTCMKTS
Ticker Symbol VNTXF

Financial Performance

In 2025, Vanta Holdings's revenue was 215,528, an increase of 164.90% compared to the previous year's 81,361. Losses were -9.82 million, 27.1% more than in 2024.

Financial numbers in CAD Financial Statements

News

Vanta Announces Strategic Private Placement Financing to Advance U.S. Peptide Market Entry and Integrated Longevity and Consumer Health Sciences Platform

VANCOUVER, BC / ACCESS Newswire / May 29, 2026 / Vanta Holdings Inc. (CSE:VNTA)(OTC:VNTXF)(FSE:7BC0, WKN:A4205J) ("Vanta" or the "Company"), a consumer health sciences company and parent of the Vanta ...

5 days ago - Accesswire

Vanta Announces Strategic Agreement to Support U.S. Peptide Market Entry Through FDA-Registered Supply Chain and Compliant Payment Processing Infrastructure; Advancing U.S.-Focused Longevity and Consumer Health Sciences Platform

News Release Highlights: Vanta enters into strategic operating and infrastructure agreement supporting the planned launch of a U.S.-focused peptide therapy and longevity platform leveraging telehealth...

6 days ago - Accesswire

Vanta Announces Closing of Second Tranche of Private Placement for Aggregate Gross Proceeds of $1 Million

VANCOUVER, BC / ACCESS Newswire / May 6, 2026 / Vanta Holdings Inc. (CSE:VNTA)(OTC:VNTXF)(FSE:7BC, WKN:A4205J) ("Vanta" or the "Company"), a consumer health sciences company and parent of the Vanta pr...

4 weeks ago - Accesswire

Vanta Announces Closing of First Tranche of Private Placement and Debt Settlement

VANCOUVER, BC / ACCESS Newswire / May 5, 2026 / Vanta Holdings Inc. (CSE:VNTA)(OTC:VNTXF)(FSE:7BC, WKN:A4205J) ("Vanta" or the "Company"), a consumer health sciences company and parent of the Vanta pr...

4 weeks ago - Accesswire